Introduction
Hospital clinicians and procurement teams often ask a simple question about any biological scaffold: what exactly is in it? For a cholecyst-derived ECM scaffold, the answer is a purposeful one. The goal of manufacturing is to keep the matrix’s structural and signaling molecules and to remove the cells that would provoke an immune response.
The Structural Framework: Collagen and Elastin
The bulk of the scaffold is a collagen-rich matrix. Researchers isolating it from porcine gallbladder delaminated the collagen-rich ECM from the tissue layer beneath the mucosa, and elastin is also present within the mesh-like network. Collagen provides tensile strength and a scaffold for cell attachment, while elastin contributes the elastic recoil that lets the matrix flex with the tissue around it. Wiley Online LibraryACS Publications
The Adhesion and Signaling Layer: Glycoproteins and GAGs
Beyond collagen and elastin, native cholecyst ECM carries the glycoproteins and glycosaminoglycans that direct cell behavior: laminin and fibronectin, which help cells attach and migrate, and GAGs, which bind growth factors and regulate water retention in the matrix. These are the molecules that turn a passive collagen sheet into a bioactive scaffold, and they are the ones most vulnerable to harsh processing.
The Bioactive Molecules: Why Processing Matters
This is where manufacturing method decides what ends up inside the product. Research from the SCTIMST group showed that the retention of major biomolecules was maximal, and autodigestion minimal, when the cholecyst was stabilized in 10% neutral buffered formalin before isolation. The same body of work notes that excess cross-linking can make biomolecules unavailable and weaken the scaffold’s bioinductive properties. In other words, more processing does not mean a better scaffold; the aim is to protect the molecular content. PubMedResearchGate
CholeDerm® is manufactured through the enzyme-free, detergent-free PrisTINE Process, and Alicorn Medical reports that the finished scaffold retains 154 biomolecules relevant to wound healing.
What Is Deliberately Not Inside
Equally important is what has been removed. A decellularized scaffold should contain no living cells and minimal cellular material, since these are the main triggers of immune rejection. Comparative work by the same research group has examined why scaffolds from different organs differ in immunogenicity, and points to differences in protein composition and biomolecules between the ECMs of the source organs. A cholecyst-derived scaffold was studied against jejunum-derived matrix for exactly this reason, and the physical, chemical, and biological properties of cholecyst scaffolds prepared by a non-detergent, non-enzymatic method were found to be similar to a commercially available porcine small intestinal submucosa. Wiley Online LibraryWiley Online Library
Why This Composition Matters Clinically
For a wound bed, this inventory maps onto the healing process directly:
|
Component |
Role in the wound |
|---|---|
|
Collagen |
Structural scaffold and tensile support |
|
Elastin |
Elasticity and flexibility of new tissue |
|
Laminin and fibronectin |
Cell attachment and migration |
|
GAGs |
Growth factor binding and moisture balance |
|
Retained biomolecules |
Signaling that supports granulation, angiogenesis and remodeling |
|
No cells |
Lower risk of immune rejection |
Conclusion
What is inside a cholecyst-derived ECM scaffold is a native collagen and elastin framework, the adhesion and signaling molecules that guide repair, and a preserved pool of bioactive molecules, all with the cells taken out. That combination, protected by gentle processing, is what CholeDerm® offers hospital wound care programs..